| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.09 |